Home > National Drug Code (NDC) > Benazepril Hydrochloride and Hydrochlorothiazide

Benazepril Hydrochloride and Hydrochlorothiazide - 0378-4725-01 - (benazepril hydrochloride and hydrochlorothiazide)

Alphabetical Index


Drug Information of Benazepril Hydrochloride and Hydrochlorothiazide

Product NDC: 0378-4725
Proprietary Name: Benazepril Hydrochloride and Hydrochlorothiazide
Non Proprietary Name: benazepril hydrochloride and hydrochlorothiazide
Active Ingredient(s): 5; 6.25    mg/1; mg/1 & nbsp;   benazepril hydrochloride and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Benazepril Hydrochloride and Hydrochlorothiazide

Product NDC: 0378-4725
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076688
Marketing Category: ANDA
Start Marketing Date: 20121203

Package Information of Benazepril Hydrochloride and Hydrochlorothiazide

Package NDC: 0378-4725-01
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4725-01)

NDC Information of Benazepril Hydrochloride and Hydrochlorothiazide

NDC Code 0378-4725-01
Proprietary Name Benazepril Hydrochloride and Hydrochlorothiazide
Package Description 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4725-01)
Product NDC 0378-4725
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name benazepril hydrochloride and hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20121203
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Strength Number 5; 6.25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Benazepril Hydrochloride and Hydrochlorothiazide


General Information